Atlanta-based CardioMEMS Inc., developer of an implantable wireless device that helps physicians monitor blood pressure in heart patients, may be breathing a little easier following a federal panel’s ...

PHILADELPHIA -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000, and many patients are in the hospital again and again. But a tiny device is ...

As Abbott seeks an expanded indication for its CardioMEMS device for patients with heart failure, it’s also hoping to win over a national coverage decision from the Centers for Medicare and Medicaid ...

Heart failure occurs when the heart can no longer pump enough blood and oxygen to support the organs in the body. According to the Heart Failure Society of America, heart failure is a growing problem, ...

PHILADELPHIA (WPVI) -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000 and many patients are in the hospital again and again. But a tiny device is ...

CLEVELAND, Ohio (WOIO) -The CardioMEMS device is permanently implanted in patients and provides doctors and nurse practitioners with daily reports. Leading indicators and stats alert the patient and ...

In a bid to fortify its Heart Failure business, AbbottABT recently announced the start of the - GUIDE-HF clinical trial - largest heart failure medical device study in the United States. The trial ...

(RTTNews) - Abbott (ABT) reported results of the GUIDE-HF clinical trial which assessed the benefits of the CardioMEMS HF System in an expanded patient population not currently approved for the device ...

WASHINGTON (Reuters) - A Food and Drug Administration review of CardioMEMS' device for treating heart failure found it has met its main safety and effectiveness goals, based on trial results. But the ...

St. Jude Medical, a medical device company and part owner of Atlanta-based CardioMEMS, plans to exercise an option to acquire all of the company now that CardioMEMS’ heart-failure monitoring device ...

WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel on Thursday decided not to recommend CardioMEMS implantable heart device for treating heart failure because supporting clinical ...